Your browser doesn't support javascript.
loading
The NINDS Parkinson's disease biomarkers program.
Rosenthal, Liana S; Drake, Daniel; Alcalay, Roy N; Babcock, Debra; Bowman, F DuBois; Chen-Plotkin, Alice; Dawson, Ted M; Dewey, Richard B; German, Dwight C; Huang, Xuemei; Landin, Barry; McAuliffe, Matthew; Petyuk, Vladislav A; Scherzer, Clemens R; Hillaire-Clarke, Coryse St; Sieber, Beth-Anne; Sutherland, Margaret; Tarn, Chi; West, Andrew; Vaillancourt, David; Zhang, Jing; Gwinn, Katrina.
  • Rosenthal LS; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Drake D; Department of Biostatistics, Columbia University, New York, New York, USA.
  • Alcalay RN; Department of Neurology, Columbia University, New York, New York, USA.
  • Babcock D; National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Bowman FD; Department of Biostatistics, Columbia University, New York, New York, USA.
  • Chen-Plotkin A; Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Dawson TM; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Dewey RB; Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Solomon H. Snyder Department of Neuroscience, Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • German DC; Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, USA.
  • Huang X; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, USA.
  • Landin B; Department of Neurology, Penn State Hershey Medical Center, Hershey, Pennsylvania, USA.
  • McAuliffe M; Center for Information Technology, National Institutes of Health, Bethesda, Maryland, USA.
  • Petyuk VA; Center for Information Technology, National Institutes of Health, Bethesda, Maryland, USA.
  • Scherzer CR; Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, USA.
  • Hillaire-Clarke CS; Department of Neurology, Brigham & Women's Hospital, Harvard Medical School, Cambridge, Massachusetts, USA.
  • Sieber BA; National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Sutherland M; National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Tarn C; National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • West A; Coriell Institute for Medical Research, Camden, New Jersey, USA.
  • Vaillancourt D; Department of Neurology, University of Alabama at Birmingham, Birmingham, USA.
  • Zhang J; Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida, USA.
  • Gwinn K; Department of Pathology, University of Washington, Seattle, Washington, USA.
Mov Disord ; 31(6): 915-23, 2016 06.
Article en En | MEDLINE | ID: mdl-26442452

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Biomarcadores / Estudios Multicéntricos como Asunto / Desarrollo de Programa / National Institute of Neurological Disorders and Stroke (U.S.) Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans País como asunto: America do norte Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Biomarcadores / Estudios Multicéntricos como Asunto / Desarrollo de Programa / National Institute of Neurological Disorders and Stroke (U.S.) Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans País como asunto: America do norte Idioma: En Año: 2016 Tipo del documento: Article